NCT04909359已完成不适用
Immunophenotypic Characterization of Crohn's Disease (CD) Responders to Vedolizumab
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 51
- 试验地点
- 1
- 主要终点
- T cell concentration
研究概览
简要总结
The purpose of this study is to characterize which patients with Crohn's disease are likely to respond to standard of care to vedolizumab therapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
T cell concentration
时间窗: up to 22 weeks
Evaluated from peripheral blood samples and lamina propria biopsies
次要结局
- Effector memory T cells concentration(up to 22 weeks)
- T regulatory cells concentration(up to 22 weeks)
研究者
Maria Abreu
Professor of Medicine
University of Miami
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Setting up a Cohort of Patients With Inflammatory Bowel Disease and a Cohort of Patients Without Chronic Inflammatory Bowel DiseaseNCT06502873Artialis120
已完成
不适用
Risk Stratification of Rapid Disease Progression in Children With Crohn's DiseaseCrohn's DiseaseNCT00790543Emory University1,813
终止
3 期
Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With ImmunosuppressantsMucosal InflammationCrohn's DiseaseNCT01562951Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa15
招募中
不适用
Immune Regulation in Ulcerative Colitis or Crohn s DiseaseChrohn's DiseaseUlcerative ColitisInflammatory Bowel DiseaseNCT00001184National Institute of Allergy and Infectious Diseases (NIAID)1,000
Unknown
不适用
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's DiseaseCrohn DiseaseNCT04135027Second Affiliated Hospital, School of Medicine, Zhejiang University500